Health Reference Library

How does low ferritin affect sleep quality independently of fatigue?

Last reviewed 29 April 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

The strongest evidence linking low ferritin to disrupted sleep operates through restless legs syndrome (RLS) and periodic limb movement disorder, both of which fragment sleep architecture. The 2024 AASM guideline recommends iron testing and repletion in clinically significant RLS, with oral iron at ferritin ≤75 µg/L and IV iron at 75-100 µg/L. These thresholds sit higher than for general iron deficiency. Whether ferritin disrupts adult sleep independently of RLS is less clear.

How it works

Brain iron deficiency in RLS has been shown through several lines of evidence: low CSF ferritin and elevated CSF transferrin (Earley 2000, Neurology); reduced substantia nigra iron on MRI (Allen 2001, Neurology); decreased H-ferritin and iron staining in post-mortem brain tissue (Connor 2003, Neurology); and altered iron transport at the blood-brain barrier (Connor 2011). Brain iron deficiency can persist at peripheral ferritin levels in the standard normal range, which is why RLS-specific ferritin thresholds sit higher than general iron-deficiency thresholds.

Safety profile

Augmentation risk (a paradoxical worsening of RLS) associated with dopamine agonists for RLS is one of the primary reasons the 2024 AASM guideline shifted toward iron and gabapentinoids as first-line. Detail belongs in the dedicated RLS entry. Self-supplementation with iron without a confirmed deficiency diagnosis can be harmful, particularly in those with hereditary haemochromatosis or other iron-loading conditions.

Special populations

The pregnancy and CKD contexts have specific RLS-aware iron testing pathways. The paediatric evidence supports a developmental relevance of iron status to sleep regulation that may not extrapolate cleanly to adults. Most adult observational evidence linking ferritin to sleep architecture is confounded by RLS prevalence. RLS is common in iron-deficient populations and may not have been formally screened in older studies, which leaves the adult independent-of-RLS question unresolved.

Guideline positions

These RLS-specific thresholds sit higher than general-population iron-deficiency cut-offs (typically <15-30 µg/L) because brain iron deficiency in RLS can persist at peripheral ferritin levels in the standard normal range. AASM 2024 also covers ESRD-specific iron management for RLS in chronic kidney disease, where a TSAT-based threshold of <20% is used.

Practical framework

Iron studies (ferritin alongside transferrin saturation) are the standard biomarker assessment. AASM 2024 advises morning testing after a 24-hour iron-supplement-free period for accurate baseline values when assessing for RLS. CRP is measured concurrently if inflammation is plausible, since ferritin is an acute-phase reactant. Sleep history should include a bed partner's report of observed leg movements during sleep where possible. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: low ferritin alone (without RLS or PLMD) reliably disrupts adult sleep architecture. The published evidence for this is limited; most adult observational evidence is confounded by RLS prevalence. Paediatric controlled studies show altered sleep architecture in iron-deficient infants and young children that resolves with iron repletion, but this developmental finding does not extrapolate cleanly to adults. Specific timing claims (sleep improvements at 4-8 weeks; REM and deep sleep changes detectable on wearables before subjective fatigue resolves) are not anchored to published RCTs.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Sources

  1. Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS 2025. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. PMID: 39324694 · DOI: 10.5664/jcsm.11390
  2. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP 2000. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. PMID: 10762522 · DOI: 10.1212/wnl.54.8.1698
  3. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ 2001. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. PMID: 11160969 · DOI: 10.1212/wnl.56.2.263
  4. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ 2003. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. PMID: 12913188 · DOI: 10.1212/01.wnl.0000078887.16593.12
  5. Allen RP, Picchietti DL, Auerbach M, Cho YW, Connor JR, Earley CJ, Garcia-Borreguero D, Kotagal S, Manconi M, Ondo W, Ulfberg J, Winkelman JW 2018. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Medicine. PMID: 29425576 · DOI: 10.1016/j.sleep.2017.11.1126
  6. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ 2011. Profile of altered brain iron acquisition in restless legs syndrome. Brain. PMID: 21398376 · DOI: 10.1093/brain/awr012

Related entries

Back to Iron overview